NYSE American - Delayed Quote USD

Xtant Medical Holdings, Inc. (XTNT)

0.9500 +0.0485 (+5.38%)
At close: April 26 at 3:59 PM EDT
0.9500 0.00 (0.00%)
After hours: April 26 at 6:19 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Sean E. Browne President, CEO & Director 1.29M -- 1966
Mr. Mark A. Schallenberger Chief Operations Officer 778.42k -- 1986
Mr. Kevin D. Brandt Senior VP & Chief Commercial Officer 658.03k -- 1966
Mr. Scott C. Neils Chief Financial Officer 517.86k -- 1984
Ms. Catherine Lundy Vice President of Human Resources -- -- --

Xtant Medical Holdings, Inc.

664 Cruiser Lane
Belgrade, MT 59714
United States
406 388 0480 https://www.xtantmedical.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
207

Description

Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons. It offers OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSelect DBM Putty to mold into any shape and compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, a growth factor enriched cellular bone matrix; and nanOss family of products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, it offers Certex spinal fixation, Spider cervical plating, Streamline OCT, CervAlign, Axle interspinous fusion, Xpress minimally invasive pedicle screw, Fortex pedicle screw, Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation systems, and Silex sacroiliac joint fusion systems. Further, it provides Calix for cervical and thoracolumbar applications, as well as Irix-C Cervical Integrated Fusion, Irix-A Lumbar Integrated Fusion, Fortilink, and Irix-A Lumbar integrated fusion systems; Coflex device for lumbar spinal stenosis; and CoFix implant for back and disc pain. The company is headquartered in Belgrade, Montana.

Corporate Governance

Xtant Medical Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 02, 2024 - May 06, 2024
Xtant Medical Holdings, Inc. Earnings Call

Related Tickers

ATEC Alphatec Holdings, Inc.
12.44
+1.63%
 
FNA Paragon 28, Inc.
8.80
-1.90%
 
SSTC SensaSure Technologies, Inc.
0.7500
0.00%
 
TMCI Treace Medical Concepts, Inc.
10.40
+0.97%
 
AXGN AxoGen, Inc.
6.63
+1.69%
 
AEGIR.ST AegirBio AB (publ)
0.5190
+4.74%
 
ELUT Elutia Inc.
2.7800
-6.40%
 
APYX Apyx Medical Corporation
1.4500
-2.03%
 
VAPO Vapotherm, Inc.
1.2500
-0.51%
 
PBIO Pressure BioSciences, Inc.
0.2268
+3.09%